Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95


Assessing the global risk of cardiovascular disease among a group of university students: population-based cross-sectional study in Yaoundé, Cameroon.

Nansseu JR, Assah F, Petnga SJ, Kameni BS, Tene HDF, Nang FT, Wouna DLA, Noubiap JJ, Kamgno J.

BMJ Open. 2019 Sep 20;9(9):e030594. doi: 10.1136/bmjopen-2019-030594.


High snakebite underreporting rate in the Centre Region of Cameroon: an observational study.

Tchoffo D, Kamgno J, Kekeunou S, Yadufashije C, Nana Djeunga HC, Nkwescheu AS.

BMC Public Health. 2019 Aug 3;19(1):1040. doi: 10.1186/s12889-019-7363-3.


Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.

Njume FN, Ghogomu SM, Shey RA, Gainkam LOT, Poelvoorde P, Humblet P, Kamgno J, Robert A, Mutesa L, Lelubre C, Edelweiss E, Poterszman A, Anheuser S, Vanhamme L, Souopgui J.

PLoS Negl Trop Dis. 2019 Jul 22;13(7):e0007591. doi: 10.1371/journal.pntd.0007591. eCollection 2019 Jul.


Do Communities Really "Direct" in Community-Directed Interventions? A Qualitative Assessment of Beneficiaries' Perceptions at 20 Years of Community Directed Treatment with Ivermectin in Cameroon.

Dissak-Delon FN, Kamga GR, Humblet PC, Robert A, Souopgui J, Kamgno J, Ghogomu SM, Godin I.

Trop Med Infect Dis. 2019 Jul 15;4(3). pii: E105. doi: 10.3390/tropicalmed4030105.


Assessment of the relationship between water insecurity, hygiene practices, and incidence of diarrhea among children from rural households of the Menoua Division, West Cameroon.

Nounkeu C, Kamgno J, Dharod J.

J Public Health Afr. 2019 Jun 12;10(1):951. doi: 10.4081/jphia.2019.951. eCollection 2019 May 3.


A test-and-not-treat strategy for onchocerciasis elimination in Loa loa co-endemic areas: cost analysis of a pilot in the Soa health district, Cameroon.

Lenk EJ, Moungui HC, Boussinesq M, Kamgno J, Nana-Djeunga HC, Fitzpatrick C, Peultier AMM, Klion AD, Nutman TB, Fletcher DA, Pion SD, Niamsi-Emalio Y, Redekop WK, Severens JL, Stolk WA.

Clin Infect Dis. 2019 Jun 4. pii: ciz461. doi: 10.1093/cid/ciz461. [Epub ahead of print]


Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.

Dissak-Delon FN, Kamga GR, Humblet PC, Robert A, Souopgui J, Kamgno J, Ghogomu SM, Godin I.

Parasit Vectors. 2019 May 20;12(1):246. doi: 10.1186/s13071-019-3497-5.


Effect of a Single Standard Dose (150-200 μg/kg) of Ivermectin on Loa loa Microfilaremia: Systematic Review and Meta-analysis.

Pion SD, Tchatchueng-Mbougua JB, Chesnais CB, Kamgno J, Gardon J, Chippaux JP, Ranque S, Ernould JC, Garcia A, Boussinesq M.

Open Forum Infect Dis. 2019 Jan 11;6(4):ofz019. doi: 10.1093/ofid/ofz019. eCollection 2019 Apr.


Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.

Boullé C, Njamnshi AK, Dema F, Mengnjo MK, Siewe Fodjo JN, Bissek AZ, Suykerbuyk P, Lenou-Nanga CG, Nana-Djeunga HC, Kamgno J, Chesnais CB, Boussinesq M, Colebunders R.

Parasit Vectors. 2019 Mar 19;12(1):114. doi: 10.1186/s13071-019-3345-7.


Loa loa microfilariae in skin snips: consequences for onchocerciasis monitoring and evaluation in L. loa endemic areas.

Nana-Djeunga HC, Fossuo-Thotchum F, Pion SD, Chesnais CB, Kubofcik J, Mackenzie CD, Klion AD, Boussinesq M, Nutman TB, Kamgno J.

Clin Infect Dis. 2019 Mar 6. pii: ciz172. doi: 10.1093/cid/ciz172. [Epub ahead of print]


Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).

Mogoung-Wafo AE, Nana-Djeunga HC, Domche A, Fossuo-Thotchum F, Bopda J, Mbickmen-Tchana S, Djomo-Kamga H, Kamgno J.

BMC Infect Dis. 2019 Feb 13;19(1):146. doi: 10.1186/s12879-019-3776-y.


Changes in the healthcare utilization after establishment of emergency centre in Yaoundé, Cameroon: A before and after cross-sectional survey analysis.

Kong SYJ, Wi DH, Ro YS, Shin SD, Jeong J, Kim YJ, Kamgno J, Alain EMG, Hollong B, Oh YJ.

PLoS One. 2019 Feb 8;14(2):e0211777. doi: 10.1371/journal.pone.0211777. eCollection 2019.


Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis.

Hertz MI, Nana-Djeunga H, Kamgno J, Jelil Njouendou A, Chawa Chunda V, Wanji S, Rush A, Fischer PU, Weil GJ, Budge PJ.

PLoS Negl Trop Dis. 2018 Nov 16;12(11):e0006963. doi: 10.1371/journal.pntd.0006963. eCollection 2018 Nov.


The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.

Chesnais CB, Nana-Djeunga HC, Njamnshi AK, Lenou-Nanga CG, Boullé C, Bissek AZ, Kamgno J, Colebunders R, Boussinesq M.

Lancet Infect Dis. 2018 Nov;18(11):1278-1286. doi: 10.1016/S1473-3099(18)30425-0. Epub 2018 Sep 26.


Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.

Shey RA, Ghogomu SM, Njume FN, Gainkam LOT, Poelvoorde P, Mutesa L, Robert A, Humblet P, Munyampundu JP, Kamgno J, Lelubre C, Vanhamme L, Souopgui J.

PLoS One. 2018 Sep 26;13(9):e0202915. doi: 10.1371/journal.pone.0202915. eCollection 2018.


Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, Kamgno J, Robert A.

Parasit Vectors. 2018 Jun 19;11(1):356. doi: 10.1186/s13071-018-2944-z.


In Southern Nigeria Loa loa Blood Microfilaria Density is Very Low Even in Areas with High Prevalence of Loiasis: Results of a Survey Using the New LoaScope Technology.

Emukah E, Rakers LJ, Kahansim B, Miri ES, Nwoke BEB, Griswold E, Saka Y, Anagbogu I, Davies E, Ityonzughul C, D'Ambrosio M, Bakalar M, Fletcher DA, Nutman T, Kamgno J, Richards FO.

Am J Trop Med Hyg. 2018 Jul;99(1):116-123. doi: 10.4269/ajtmh.18-0163. Epub 2018 May 10.


Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Loa loa Microfilariaemia with Prolonged Repeated Courses of Albendazole.

Arrey-Agbor DB, Nana-Djeunga HC, Mogoung-Wafo AE, Mafo M, Danwe C, Kamgno J.

Am J Trop Med Hyg. 2018 Jul;99(1):112-115. doi: 10.4269/ajtmh.17-0664. Epub 2018 May 3.


Report of the first international workshop on onchocerciasis-associated epilepsy.

Colebunders R, Mandro M, Njamnshi AK, Boussinesq M, Hotterbeekx A, Kamgno J, O'Neill S, Hopkins A, Suykerbuyk P, Basáñez MG, Post RJ, Pedrique B, Preux PM, Stolk WA, Nutman TB, Idro R.

Infect Dis Poverty. 2018 Mar 22;7(1):23. doi: 10.1186/s40249-018-0400-0.


Treating Onchocerciasis in Regions in Which Loa loa Is Endemic.

Pion SD, Boussinesq M, Kamgno J.

N Engl J Med. 2018 Mar 1;378(9):871-872. doi: 10.1056/NEJMc1716788. No abstract available.


Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.

Kamgno J, Nana-Djeunga HC, Pion SD, Chesnais CB, Klion AD, Mackenzie CD, Nutman TB, Boussinesq M.

Int Health. 2018 Mar 1;10(suppl_1):i49-i53. doi: 10.1093/inthealth/ihx051.


A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.

Kamgno J, Pion SD, Chesnais CB, Bakalar MH, D'Ambrosio MV, Mackenzie CD, Nana-Djeunga HC, Gounoue-Kamkumo R, Njitchouang GR, Nwane P, Tchatchueng-Mbouga JB, Wanji S, Stolk WA, Fletcher DA, Klion AD, Nutman TB, Boussinesq M.

N Engl J Med. 2017 Nov 23;377(21):2044-2052. doi: 10.1056/NEJMoa1705026. Epub 2017 Nov 8.


Familial Aggregation and Heritability of Loa loa Microfilaremia.

Eyebe S, Sabbagh A, Pion SD, Nana-Djeunga HC, Kamgno J, Boussinesq M, Chesnais CB.

Clin Infect Dis. 2018 Feb 10;66(5):751-757. doi: 10.1093/cid/cix877.


Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.

Walker M, Pion SDS, Fang H, Gardon J, Kamgno J, Basáñez MG, Boussinesq M.

Clin Infect Dis. 2017 Nov 29;65(12):2026-2034. doi: 10.1093/cid/cix616.


Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.

Dissak-Delon FN, Kamga GR, Humblet PC, Robert A, Souopgui J, Kamgno J, Essi MJ, Ghogomu SM, Godin I.

PLoS Negl Trop Dis. 2017 Aug 14;11(8):e0005849. doi: 10.1371/journal.pntd.0005849. eCollection 2017 Aug.


Important progress towards elimination of onchocerciasis in the West Region of Cameroon.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, Kamgno J, Robert A.

Parasit Vectors. 2017 Aug 3;10(1):373. doi: 10.1186/s13071-017-2301-7.


Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Doyle SR, Bourguinat C, Nana-Djeunga HC, Kengne-Ouafo JA, Pion SDS, Bopda J, Kamgno J, Wanji S, Che H, Kuesel AC, Walker M, Basáñez MG, Boakye DA, Osei-Atweneboana MY, Boussinesq M, Prichard RK, Grant WN.

PLoS Negl Trop Dis. 2017 Jul 26;11(7):e0005816. doi: 10.1371/journal.pntd.0005816. eCollection 2017 Jul.


First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.

Nana-Djeunga HC, Tchouakui M, Njitchouang GR, Tchatchueng-Mbougua JB, Nwane P, Domche A, Bopda J, Mbickmen-Tchana S, Akame J, Tarini A, Epée E, Biholong BD, Zhang Y, Tougoue JJ, Kabore A, Njiokou F, Kamgno J.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005633. doi: 10.1371/journal.pntd.0005633. eCollection 2017 Jun.


Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.

Herrick JA, Legrand F, Gounoue R, Nchinda G, Montavon C, Bopda J, Tchana SM, Ondigui BE, Nguluwe K, Fay MP, Makiya M, Metenou S, Nutman TB, Kamgno J, Klion AD.

Clin Infect Dis. 2017 Apr 15;64(8):1017-1025. doi: 10.1093/cid/cix016.


Evaluation of demands, usage and unmet needs for emergency care in Yaoundé, Cameroon: a cross-sectional study.

Ro YS, Shin SD, Jeong J, Kim MJ, Jung YH, Kamgno J, Alain EM, Hollong B.

BMJ Open. 2017 Feb 6;7(2):e014573. doi: 10.1136/bmjopen-2016-014573.


Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Mbigha-Ghogomu S, Souopgui J, Zoure HG, Boussinesq M, Kamgno J, Robert A.

Parasit Vectors. 2016 Nov 14;9(1):581.


Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.

Pion SD, Montavon C, Chesnais CB, Kamgno J, Wanji S, Klion AD, Nutman TB, Boussinesq M.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1417-1423. doi: 10.4269/ajtmh.16-0547. Epub 2016 Oct 10.


Prevalence and intensity of human soil transmitted helminth infections in the Akonolinga health district (Centre Region, Cameroon): Are adult hosts contributing in the persistence of the transmission?

Bopda J, Nana-Djeunga H, Tenaguem J, Kamtchum-Tatuene J, Gounoue-Kamkumo R, Assob-Nguedia C, Kamgno J.

Parasite Epidemiol Control. 2016 Mar 22;1(2):199-204. doi: 10.1016/j.parepi.2016.03.001. eCollection 2016 Jun.


Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.

Kamgno J, Nguipdop-Djomo P, Gounoue R, Téjiokem M, Kuesel AC.

PLoS Negl Trop Dis. 2016 Mar 11;10(3):e0004492. doi: 10.1371/journal.pntd.0004492. eCollection 2016 Mar.


Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.

Gounoue-Kamkumo R, Nana-Djeunga HC, Bopda J, Akame J, Tarini A, Kamgno J.

BMC Infect Dis. 2015 Dec 23;15:579. doi: 10.1186/s12879-015-1317-x.


Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination.

Nana-Djeunga HC, Tchatchueng-Mbougua JB, Bopda J, Mbickmen-Tchana S, Elong-Kana N, Nnomzo'o E, Akame J, Tarini A, Zhang Y, Njiokou F, Kamgno J.

PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0004001. doi: 10.1371/journal.pntd.0004001. eCollection 2015.


Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope.

D'Ambrosio MV, Bakalar M, Bennuru S, Reber C, Skandarajah A, Nilsson L, Switz N, Kamgno J, Pion S, Boussinesq M, Nutman TB, Fletcher DA.

Sci Transl Med. 2015 May 6;7(286):286re4. doi: 10.1126/scitranslmed.aaa3480.


Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.

Bennuru S, Pion SD, Kamgno J, Wanji S, Nutman TB.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3180. doi: 10.1371/journal.pntd.0003180. eCollection 2014 Sep.


Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.

Nana-Djeunga HC, Bourguinat C, Pion SD, Bopda J, Kengne-Ouafo JA, Njiokou F, Prichard RK, Wanji S, Kamgno J, Boussinesq M.

PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2824. doi: 10.1371/journal.pntd.0002824. eCollection 2014 Apr.


Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection.

Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB.

J Clin Microbiol. 2014 Jun;52(6):2071-7. doi: 10.1128/JCM.00525-14. Epub 2014 Apr 2.


Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.

Fokom-Domgue J, Pion SD, Gounoue R, Akame J, Nguipdop-Djomo P, Twum-Danso NA, Thylefors B, Boussinesq M, Kamgno J.

Am J Trop Med Hyg. 2014 Feb;90(2):335-8. doi: 10.4269/ajtmh.13-0189. Epub 2014 Jan 13.


Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.

Kouam MK, Tchatchueng-Mbougua JB, Demanou M, Boussinesq M, Pion SD, Kamgno J.

Parasit Vectors. 2013 Sep 27;6(1):283. doi: 10.1186/1756-3305-6-283.


Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon.

Katabarwa MN, Eyamba A, Nwane P, Enyong P, Kamgno J, Kueté T, Yaya S, Aboutou R, Mukenge L, Kafando C, Siaka C, Mkpouwoueiko S, Ngangue D, Biholong BD, Andze GO.

J Parasitol Res. 2013;2013:420928. doi: 10.1155/2013/420928. Epub 2013 Apr 17.


Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Pion SD, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, Njiokou F, Prichard RK, Boussinesq M.

PLoS Negl Trop Dis. 2013;7(2):e2084. doi: 10.1371/journal.pntd.0002084. Epub 2013 Feb 28.


Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.

Nana-Djeunga H, Bourguinat C, Pion SD, Kamgno J, Gardon J, Njiokou F, Boussinesq M, Prichard RK.

Mol Biochem Parasitol. 2012 Sep;185(1):10-8. doi: 10.1016/j.molbiopara.2012.05.005. Epub 2012 Jun 5.


Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia.

Fink DL, Kamgno J, Nutman TB.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1299. doi: 10.1371/journal.pntd.0001299. Epub 2011 Aug 30.


Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.

Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG.

Am J Trop Med Hyg. 2010 Jul;83(1):28-32. doi: 10.4269/ajtmh.2010.09-0734.


Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.

Pion SD, Grout L, Kamgno J, Nana-Djeunga H, Boussinesq M.

Acta Trop. 2011 Sep;120 Suppl 1:S91-9. doi: 10.1016/j.actatropica.2010.05.004. Epub 2010 May 24.


A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.

Kamgno J, Djomo PN, Pion SD, Thylefors B, Boussinesq M.

Am J Trop Med Hyg. 2010 Mar;82(3):379-85. doi: 10.4269/ajtmh.2010.09-0573.


Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.

Kamgno J, Pion SD, Mackenzie CD, Thylefors B, Boussinesq M.

Am J Trop Med Hyg. 2009 Dec;81(6):1056-61. doi: 10.4269/ajtmh.2009.09-0356.


Supplemental Content

Loading ...
Support Center